NFE2L2 and chronic obstructive pulmonary disease: Alveolar macrophages from S (n = 8) and COPD patients (n = 8) were treated with Nrf2 activators for 24 h and mRNA expression levels of HMOX1, SOD1 and TXNRD1 were measured.